Cancer Drug Trial Boosts Biotech Names

Kim Kahn covers Genentech's Phase 3 success for giradestrant and the impact on Aleima Pharmaceuticals.

Play episode from 02:19

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!